TTY Biopharm and PharmaMar entered into an exclusive agreement to commercialize Yondelis® in Taiwan, Hong Kong and Macao
2020.6.9
...
TS-1® Capsule received TW NHI approval for Treatment of Patients with Locally Advanced or Metastatic Non-small Cell Lung Cancer
2020.1.31
最新消息
...
LONSURF® get NHI reimbursement for metastatic colorectal cancer treatment since Dec/01/2018.
2018.11.16
最新消息
...